Creative Testing Solutions CEO and leadership

Gene Robertson is a Laboratory Operations Executive and Senior Scientist with nearly 30 years of industrial health care experience. Serving currently as VP Integration for laboratory merger activities between Creative Testing Solutions and the American Red Cross.

Ms. Shah is legal counsel and assistant secretary for Creative Testing Solutions. Ms. Shah oversees the Legal Department at Vitalant and is responsible for areas of legal compliance and for providing legal counsel to executives and governing boards on mergers and acquisitions, governance, strategic planning, operations, human resources, regulatory compliance, risk management, intellectual property and litigation. She also provides legal counsel to Vitalents’ other divisions, affiliates and subsidiaries. Prior to joining Vitalant, Ms. Shah served as Assistant General Counsel at Phoenix Children’s Hospital, Associate Counsel at Cold Stone Creamery and worked at the law firm of Snell & Wilmer, LLP. She received her J.D. from the University of Kansas School of Law and belongs to the American Health Lawyers Association, the Association of Corporate Counsel and the Arizona Association of Corporate Counsel.

I currently serve as Chief Scientific Officer for Creative Testing Solutions (CTS). Creative Testing Solutions is the largest blood and plasma donor screening laboratory system in the world. The CTS network consists of eight FDA regulated laboratories which are geographically distributed throughout the US (Austin, Charlotte, Dallas, Memphis, Phoenix, San Marcos, St. Louis, and Tampa). CTS currently performs infectious disease screening for approximately 75% of the US blood supply on an annual basis.

As CTS’ Chief Scientific Officer, I am responsible for the quality monitoring of our donor testing laboratories, the oversight of our Medical Directors and CLIA licenses, review of procedures, validations, and clinical programs, all research activities, and the operations of all CTS Specialty laboratories. CTS' testing volume also provides a unique ability to continually monitor a diverse data set generated from donor specimens which are grossly representative of the US population. This allows an unprecedented opportunity to study the epidemiology, genetics and associated clinical manifestations of emerging infectious disease, while also providing the distinct ability to improve blood product safety and to rapidly respond to emerging infectious disease threats in the US.

I have a strong background in molecular biology with an emphasis in microbial genetics and specific expertise in the development of rapid nucleic acid and immunologic diagnostic systems, as well as methods and tools for the rapid assessment of disease outbreaks.

Tanya Perry is the Chief Financial Officer for Creative Testing Solutions (CTS) and has served in this capacity since 2020.

She brings more than 20 years of diverse financial leadership experience, most recently in an executive leadership role with a large Phoenix nonprofit. In her role as CFO, she directs the financial strategies of the organization and oversees the accounting and finance functions, risk management, supply chain and internal audit. She is a licensed CPA and holds an executive MBA from Arizona State University.